FDA Milk Sampling Program Begins
January 6, 2012
The Food and Drug Administration (FDA) milk residue survey project is now underway. The FDA residue survey involves the collection of a total of nearly 2,000 universal milk samples at central milk testing laboratories: 900 milk samples from dairy producers with a cull dairy cow tissue residue violation, and another 900 random milk samples. FDA will have the samples blinded at the central laboratories, and then shipped to the Institute for Food Safety and Health (IFSH) at Illinois Institute of Technology.
The milk samples will then be shipped to FDA laboratories for analysis. The milk samples will be tested for about 30 different antimicrobial and anti-inflammatory residues which may include the following: Ampicillin, Cephapirin, Cloxacillin, Penicillin G, Erythromycin, Tylosin, Ciprofloxacin, Sarafloxacin, Chlortetracycline, Oxytetracycline, Tetracycline, Doxycycline, Sulfachloropyridazine, Sulfadiazine, Sulfamerazine, Sulfadimethoxine,Sulfamethazine, Sulfaquinoxaline, Sulfathiazole, Tripelennamine,Thiabendazole, Pirlimycin, Flunixin, Bacitracin, Virginiamycin, Tilmicosin, Neomycin, Gentamicin, Florfenicol, Chloramphenicol and Tulathromycin.
NMPF anticipates that the sampling and laboratory analysis will take about one year. As a reminder, the NMPF Milk and Dairy Beef Drug Residue Prevention Manual is available on the National Dairy FARM Program website.